Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNF4 | P78317 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 2/20 | 0.46 |
| ▸ | BCL2A1 | Q16548 | 2/20 | 0.45 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.45 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.45 |
| ▸ | PGR | P06401 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5702218 | 0.95 | RNF4 (0.51) | RNF4SMN1; SMN2TSHRALDH1A1BCL2A1 | |
| SCHEMBL249712 | 0.90 | RNF4 (0.48) | RNF4SMN1; SMN2TSHRALDH1A1BCL2A1 | |
| SCHEMBL15984777 | 0.81 | SMN1; SMN2 (0.62) | RNF4SMN1; SMN2TSHRALDH1A1BCL2A1 | |
| SCHEMBL11875667 | 0.79 | SMN1; SMN2 (0.47) | RNF4SMN1; SMN2TSHRALDH1A1BCL2A1 | |
| SCHEMBL14577947 | 0.79 | TSHR (0.49) | RNF4SMN1; SMN2TSHRALDH1A1PARP10 | |
| SCHEMBL5454456 | 0.79 | HTT (0.51) | RNF4SMN1; SMN2TSHRALDH1A1BCL2A1 | |
| SCHEMBL7044788 | 0.78 | TSHR (0.51) | RNF4TSHRALDH1A1BCL2A1TRPM8 | |
| SCHEMBL6801988 | 0.78 | TSHR (0.58) | SMN1; SMN2TSHRALDH1A1MAPTL3MBTL1 | |
| SCHEMBL545097 | 0.78 | TSHR (0.45) | RNF4SMN1; SMN2TSHRALDH1A1BCL2A1 | |
| SCHEMBL15054523 | 0.78 | RNF4 (0.49) | RNF4TSHRALDH1A1BCL2A1TRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9517651-B2 | Developer for thermal recording media and thermal composition media using the same | PERFORMANCE CHEMICALS, INC. (US) | 2016-12-13 | — | — | US | disclosed |
| US-20160089919-A1 | NOVEL DEVELOPER FOR THERMAL RECORDING MEDIA AND THERMAL COMPOSITION MEDIA USING THE SAME | MARUBENI AMERICA CORPORATION | 2016-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160089919-A1 | NOVEL DEVELOPER FOR THERMAL RECORDING MEDIA AND THERMAL COMPOSITION MEDIA USING THE SAME | HPD, PNMT, HTR3C | RNF4 870/4885SMN1; SMN2 3135/4885TSHR 3887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.